Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Truscreen Group.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Memphasys tumbles almost 30pc after cow pregnancy trial disappoints
News
Market Highlights: Netflix fuels tech rally, the bullish case for iron ore, and 5 ASX small caps to watch
Health & Biotech
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
Health & Biotech
ASX Health Stocks: Arovella to develop a world-first iNKT cell therapy targeting cancers
News
Market Highlights: Euro inflation hits record high and 5 ASX small caps to watch on Thursday
Health & Biotech
ASX Health Stocks: Hope for cervical cancer patients as TruScreen announces success in China
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
IPO Watch
IPO Watch: These IPOs have been late bloomers but have come to life in the last fortnight
News
Closing Bell: ASX shrugs it off with another day of gains as investors clamour for more IPOs
News
ASX Small Cap Lunch Wrap: Who’s taking oil to the extreme today?
News
10 at 10: These ASX stocks are going off like fireworks this morning
Health & Biotech
ASX Health Stocks: Memphasys jumps on legal settlement after flaw with its Felix sperm-separating device
IPO Watch
IPO Watch: Clarity Pharmaceuticals joins the ASX after completing $92m IPO
News
Last Orders: After last week’s 2 per cent gain, ASX begins this week lower
IPO Watch
